Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. (Q38592538)

4 September 2017

title

Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. (English)

1 reference

4 September 2017

0 references

Sahdeo Prasad

1

1 reference

4 September 2017

Amit K Tyagi

series ordinal

2

1 reference

4 September 2017

language of work or name

1 reference

25 September 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

6

1 reference

4 September 2017

issue

11

1 reference

4 September 2017

page(s)

3412-3419

1 reference

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

4 September 2017

cites work

1 reference

Following the Path of the Virus: The Exploitation of Host DNA Repair Mechanisms by Retroviruses

21 January 2018

1 reference

Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal

21 January 2018

1 reference

PEPFAR support for the scaling up of collaborative TB/HIV activities

21 January 2018

1 reference

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

Multitargeting by curcumin as revealed by molecular interaction studies

21 January 2018

1 reference

Protective effect of curcumin against cytomegalovirus infection in Balb/c mice

21 January 2018

1 reference

Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?

21 January 2018

1 reference

Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice.

21 January 2018

1 reference

The effect of curcumin and cotrimoxazole in salmonella typhimurium infection in vivo

21 January 2018

1 reference

Protective mechanism of curcumin against Vibrio vulnificus infection.

21 January 2018

1 reference

The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NF-kappaB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection

21 January 2018

1 reference

Curcumin treatment provides protection against Trypanosoma cruzi infection

21 January 2018

1 reference

Curcumin for malaria therapy

21 January 2018

1 reference

Curcumin-artemisinin combination therapy for malaria

21 January 2018

1 reference

Curcumin, a component of golden spice: from bedside to bench and back

21 January 2018

1 reference

A novel polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens.

21 January 2018

1 reference

Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?

21 January 2018

1 reference

Design and development of curcumin bioconjugates as antiviral agents

21 January 2018

1 reference

Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment

21 January 2018

1 reference

Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models

21 January 2018

1 reference

Curcumin analogues with potent and selective anti-proliferative activity on acute promyelocytic leukemia: involvement of accumulated misfolded nuclear receptor co-repressor (N-CoR) protein as a basis for selective activity

21 January 2018

1 reference

Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes

21 January 2018

1 reference

Active site binding modes of curcumin in HIV-1 protease and integrase

21 January 2018

1 reference

Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties.

21 January 2018

1 reference

Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

21 January 2018

1 reference

Inhibition of human immunodeficiency virus type-1 integrase by curcumin

21 January 2018

1 reference

Curcumin Analogs with Altered Potencies against HIV-1 Integrase as Probes for Biochemical Mechanisms of Drug Action

21 January 2018

1 reference

Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression

21 January 2018

1 reference

HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation

21 January 2018

1 reference

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

21 January 2018

1 reference

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat

21 January 2018

1 reference

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication

21 January 2018

1 reference

Curcumin inhibits ultraviolet light induced human immunodeficiency virus gene expression

21 January 2018

1 reference

Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro

21 January 2018

1 reference

HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta

21 January 2018

1 reference

Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C.

21 January 2018

1 reference

Curcumin attenuates ischemia-like injury induced IL-1β elevation in brain microvascular endothelial cells via inhibiting MAPK pathways and nuclear factor-κB activation.

21 January 2018

1 reference

Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevity

21 January 2018

1 reference

Extreme elevation of ferritin and creatine kinase in primary infection with HIV-1.

21 January 2018

1 reference

HIV-1 Nef perturbs the function, structure, and signaling of the Golgi through the Src kinase Hck.

21 January 2018

1 reference

Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics

21 January 2018

1 reference

Phosphorylation of HIV Nef by cAMP-dependent protein kinase.

21 January 2018

1 reference

Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).

21 January 2018

1 reference

Inhibition of tumor necrosis factor by curcumin, a phytochemical

21 January 2018

1 reference

Nuclear factor-kappaB and STAT3 are constitutively active in CD138 cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

21 January 2018

1 reference

Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein-homology protein, glucose-related protein 78, eukaryotic initiation factor 2 alpha, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus

21 January 2018

1 reference

AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Treatment of HIV-associated diarrhea with curcumin

21 January 2018

1 reference

Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin

21 January 2018

1 reference

Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells.

21 January 2018

1 reference

HIV neurotoxicity: potential therapeutic interventions

21 January 2018

1 reference

Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis

21 January 2018

1 reference

Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats

21 January 2018

1 reference

Enhanced systemic exposure of saquinavir via the concomitant use of curcumin-loaded solid dispersion in rats

21 January 2018

1 reference

Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells

21 January 2018

1 reference

Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries

21 January 2018

1 reference

Curcumin as a promising antifungal of clinical interest.

21 January 2018

1 reference

Therapeutic roles of curcumin: lessons learned from clinical trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1039/C5FO00485C

1 reference

4 September 2017

1 reference